Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INHALE-1st
NCT07224321Phase 2Recruiting
- Sponsor
- MannKind
- Start
- Feb 2026
- Primary completion
- Mar 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Technosphere insulin in type 1 diabetes mellitus (T1D), sponsored by MannKind. Started Feb 2026; status: recruiting.
02
Drugs
Technosphere insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07224321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07224321.